Applied Finance Capital Management, LLC

Position in JNJ — Johnson & Johnson

CIK 1966007 SAN JUAN, PR

Position in JNJ

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$6,502,647

-$2,584,410 QoQ

Shares Held

25,604

-31.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.49%

of 13F equity value

Holder Rank

#1,414

of 4,664 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 97% Shared 0% None 3%

Healthcare · as of Jun 30, 2026

Applied Finance Capital Management, LLC holds $53,647,387 across 10 Drug Manufacturers - General names. JNJ ranks #3 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	133,454	$17,148,839
2	LLY	ELI LILLY & Co	12,549	$15,051,648
3	JNJ	Johnson & Johnson This page	25,604	$6,502,647
4	ABBV	AbbVie Inc.	25,128	$6,323,209
5	AMGN	Amgen Inc	6,845	$2,478,711
6	BMY	Bristol Myers Squibb Co	35,950	$2,071,439
7	GILD	Gilead Sciences, Inc.	14,693	$1,856,313
8	NVS	Novartis AG	6,260	$981,067

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,502,647	25,604	-31.1%	Shares	Sole	2026-07-28
2026-03-31	$9,087,057	37,175	-3.8%	Shares	Sole	2026-05-04
2025-12-31	$7,993,443	38,625	+41.9%	Shares	Sole	2026-02-05
2025-09-30	$5,046,946	27,219	-9.6%	Shares	Sole	2025-11-06
2025-06-30	$4,598,691	30,106	-6.5%	Shares	Sole	2025-07-29
2025-03-31	$5,337,560	32,185	+12.6%	Shares	Sole	2025-05-07
2024-12-31	$4,134,830	28,591	-2.8%	Shares	Sole	2025-02-13
2024-09-30	$4,766,508	29,412	+13.7%	Shares	Sole	2024-11-08
2024-06-30	$3,781,305	25,871	+1331.7%	Shares	Sole	2024-07-31
2024-03-31	$285,849	1,807	-0.7%	Shares	Sole	2024-05-07
2023-12-31	$285,110	1,819	+2.3%	Shares	Sole	2024-02-08
2023-09-30	$276,923	1,778	-4.1%	Shares	Sole	2023-11-08
2023-06-30	$306,874	1,854	+10.6%	Shares	Sole	2023-08-14
2023-03-31	$259,780	1,676	+11.4%	Shares	Sole	2023-05-12
2022-12-31	$265,858	1,505	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.